These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2040923)

  • 21. Kinetic modeling of plasma leucine levels during continuous venovenous extracorporeal removal therapy in neonates with maple syrup urine disease.
    Jouvet P; Hubert P; Saudubray JM; Rabier D; Man NK
    Pediatr Res; 2005 Aug; 58(2):278-82. PubMed ID: 16085796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metabolic disorders of branched-chain amino acids: most common forms of organic aciduria in the neonatal period].
    Sperl W; Lehnert W
    Klin Padiatr; 1990; 202(5):334-9. PubMed ID: 2214593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microangiopathic hemolytic anemia, thrombocytopenia, and renal injury during continuous venovenous hemodialysis in a neonate.
    Sherbotie JR
    Pediatr Nephrol; 1995 Dec; 9(6):789-90. PubMed ID: 8747129
    [No Abstract]   [Full Text] [Related]  

  • 24. Inborn errors of metabolism associated with unusual odors.
    Carpenter DG; Carter CH
    J Fla Med Assoc; 1970 May; 57(5):31-3. PubMed ID: 5449191
    [No Abstract]   [Full Text] [Related]  

  • 25. The utility of dried blood spot monitoring of branched-chain amino acids for maple syrup urine disease: A retrospective chart review study.
    Kaur J; Nagy L; Wan B; Saleh H; Schulze A; Raiman J; Inbar-Feigenberg M
    Clin Chim Acta; 2020 Jan; 500():195-201. PubMed ID: 31678570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal dialysis in maple-syrup-urine disease: studies on branched-chain amino and keto acids.
    Wendel U; Becker K; Przyrembel H; Bulla M; Manegold C; Mench-Hoinowski A; Langenbeck U
    Eur J Pediatr; 1980 Jun; 134(1):57-63. PubMed ID: 7408911
    [No Abstract]   [Full Text] [Related]  

  • 27. Continuous venovenous hemofiltration in neonates with hyperammonemia. A case series.
    Cavagnaro Santa María F; Roque Espinosa J; Guerra Hernández P
    Rev Chil Pediatr; 2018 Feb; 89(1):74-78. PubMed ID: 29664506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.
    Jan W; Zimmerman RA; Wang ZJ; Berry GT; Kaplan PB; Kaye EM
    Neuroradiology; 2003 Jun; 45(6):393-9. PubMed ID: 12736767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maple-syrup-urine disease.
    Wendel U; Lombeck I; Bremer HJ
    N Engl J Med; 1983 May; 308(18):1100-1. PubMed ID: 6835327
    [No Abstract]   [Full Text] [Related]  

  • 30. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
    Snyderman SE; Goldstein F; Sansaricq C; Norton PM
    Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intercurrent illness in inborn errors of intermediary metabolism.
    Dixon MA; Leonard JV
    Arch Dis Child; 1992 Nov; 67(11):1387-91. PubMed ID: 1471895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous hemodiafiltration in the treatment of hyperammonemia due to methylmalonic acidemia.
    Chen CY; Tsai TC; Lee WJ; Chen HC
    Ren Fail; 2007; 29(6):751-4. PubMed ID: 17763173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exchange transfusion in acute episodes of maple syrup urine disease. Studies on branched-chain amino and keto acids.
    Wendel U; Langenbeck U; Lombeck I; Bremer HJ
    Eur J Pediatr; 1982 Jul; 138(4):293-6. PubMed ID: 7128634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Removal of amino acids by continuous hemofiltration and hemodiafiltration].
    Gouyon JB; Françoise M; Desgres J; Petion AM; Sandre D
    Arch Pediatr; 1994 May; 1(5):501-4. PubMed ID: 7951837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Maple syrup urine disease and cystathioninemia].
    Simma B; Sperl W; Berger H
    Padiatr Padol; 1989; 24(1):69-75. PubMed ID: 2497426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple exchange transfusions as treatment during the acute period in maple syrup urine disease.
    Schuchmann L; Witt I; Schulz P; Schumacher H; Rüdiger H
    Helv Paediatr Acta; 1972 Sep; 27(4):449-56. PubMed ID: 4644280
    [No Abstract]   [Full Text] [Related]  

  • 37. Prospective study of maple-syrup-urine disease for the first four days of life.
    DiGeorge AM; Rezvani I; Garibaldi LR; Schwartz M
    N Engl J Med; 1982 Dec; 307(24):1492-5. PubMed ID: 7144815
    [No Abstract]   [Full Text] [Related]  

  • 38. Differential response to renal replacement therapy in neonatal-onset inborn errors of metabolism.
    Porta F; Peruzzi L; Bonaudo R; Pieretti S; Busso M; Cocchi E; Conio A; Pagliardini V; Spada M
    Nephrology (Carlton); 2018 Oct; 23(10):957-961. PubMed ID: 29888426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of a Woman With Maple Syrup Urine Disease During Pregnancy, Delivery, and Lactation.
    Wessel AE; Mogensen KM; Rohr F; Erick M; Neilan EG; Chopra S; Levy HL; Gray KJ; Wilkins-Haug L; Berry GT
    JPEN J Parenter Enteral Nutr; 2015 Sep; 39(7):875-9. PubMed ID: 24618664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute Pancreatitis in a Patient with Maple Syrup Urine Disease: A Management Paradox.
    Gold NB; Blumenthal JA; Wessel AE; Stein DR; Scott A; Fox VL; Turner A; Kritzer A; Rajabi F; Peeler K; Tan WH
    J Pediatr; 2018 Jul; 198():313-316. PubMed ID: 29681447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.